Folkert H van Bruggen

4PUBLICATIONS
5CO-AUTHORS
Respiratory diseasesCancer therapy (excl. chemotherapy and radiation therapy)Oncology and carcinogenesis not elsewhere classified
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Jul 20, 2026
Mortality in FOURIER Participants With Diabetes: A Regulatory-Data Reanalysis of Evolocumab Outcomes.

|Jul 03, 2026
Early Weight Regain After GLP-1 Receptor Agonist Discontinuation: Mechanisms and Implications for Treatment De-Escalation Strategies.

|Aug 14, 2024
Time Gained to Cardiovascular Disease by Intensive Lipid-Lowering Therapy: Results of Individual Placebo-Controlled Trials and Pooled Effects.

Folkert H van Bruggen, Esther C de Haas, Sytse U Zuidema

|May 19, 2021
Evolocumab's Long-Term Mortality Risk Unclear Due to Shortened Follow-Up of FOURIER.

Folkert H van Bruggen, Hendrika J Luijendijk

Pageof 1

Frequent Collaborators

1 joint publications

M A Damhof

1 joint publications

J Erviti

1 joint publications

L C Saiz

1 joint publications

J M Wright